跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Fibroblast growth factor-2
首页
药物
Fibroblast growth factor-2
Fibroblast growth factor-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
MONOCLONAL ANTIBODIES TO FIBROBLAST GROWTH FACTOR RECEPTOR 2
EP 3783024 A1
申请人: GALAXY BIOTECH LLC
优先权: 2008
EP
US
WO
18 件公开
CELL CULTURE MEDIUM FOR CULTURING ORGANOID, CULTURE METHOD, AND ORGANOID
EP 3690021 A1
申请人: UNIV KEIO
优先权: 2016
CN
EP
US
WO
13 件公开
SALTS OF AN FGFR INHIBITOR
EP 3788046 B1
申请人: INCYTE CORP
优先权: 2018
CN
EP
US
WO
11 件公开
ANTI-FGFR2 ANTIBODIES IN COMBINATION WITH CHEMOTHERAPY AGENTS IN CANCER TREATMENT
EP 4650004 A3
申请人: FIVE PRIME THERAPEUTICS INC
优先权: 2017
CN
EP
US
WO
10 件公开
Differentiation of whole bone marrow
US 7129034 B2
申请人: CEDARS SINAI MEDICAL CENTER
优先权: 2002
US
8 件公开
Truncated 24kDa basic fibroblast growth factor
US 7432243 B2
申请人: SCRIPPS RESEARCH INST
优先权: 2003
US
6 件公开
Methods and compositions for the treatment of peripheral artery disease
US 7186407 B2
申请人: CHIRON CORP
优先权: 2001
US
5 件公开
Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins
US 8481038 B2
申请人: KEER HAROLD
优先权: 2011
US
5 件公开
DEGRADERS OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 (FGFR2)
EP 3952863 A4
申请人: DANA FARBER CANCER INST INC
优先权: 2019
CN
EP
US
WO
4 件公开
ACIDIC FIBROBLAST GROWTH FACTOR EYE DROP PREPARATION
EP 4670710 A4
申请人: SHANGHAI TENRY PHARMACEUTICAL CO LTD
优先权: 2023
CN
EP
US
WO
4 件公开
第 1 / 10 页
上一页
下一页
药物
反馈